Zealand Pharma A/S
ZLDPF
$40.99
-$0.01-0.02%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 728.17% | 753.45% | 1,094.80% | -58.70% | -53.35% |
| Total Depreciation and Amortization | 8.27% | 1.80% | 4.59% | -18.18% | 14.44% |
| Total Amortization of Deferred Charges | 34.81% | 1,264.45% | 1,264.45% | 1,264.45% | 1,264.45% |
| Total Other Non-Cash Items | -825.81% | 1,289.52% | 1,057.36% | -102.67% | -104.54% |
| Change in Net Operating Assets | -1.24% | -228.97% | -281.05% | -163.84% | 131.28% |
| Cash from Operations | 834.30% | 1,220.15% | 1,666.02% | -162.14% | -118.54% |
| Capital Expenditure | -249.56% | -16.40% | 10.62% | 6.61% | 10.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 67.57% | 75.66% | -476.62% | -128.42% | -578.94% |
| Cash from Investing | 67.12% | 75.45% | -470.45% | -126.71% | -572.93% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -- |
| Total Debt Repaid | -22.62% | 8.39% | 7.68% | 96.89% | 96.97% |
| Issuance of Common Stock | -99.42% | -99.62% | -99.58% | 134.22% | 445.00% |
| Repurchase of Common Stock | -15.73% | -15.73% | -644.43% | -745.75% | -745.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 99.96% | 98.95% | -125.22% | -229.00% |
| Cash from Financing | -104.83% | -105.02% | -107.10% | 136.98% | 804.10% |
| Foreign Exchange rate Adjustments | -971.11% | -1,294.00% | -6,055.31% | -109.74% | 186.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,965.13% | 43,574.88% | -98.86% | -58.93% | 86.92% |